echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > PLOS Med: Antiemetic, analgesic, anti-inflammatory... Analysis of the safety and tolerability of medicinal cannabinoids

    PLOS Med: Antiemetic, analgesic, anti-inflammatory... Analysis of the safety and tolerability of medicinal cannabinoids

    • Last Update: 2021-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For thousands of years, the cannabis plant has been used for recreational and medicinal purposes throughout the world.


    Starting from October 17, 2018, recreational marijuana is officially recognized by law in Canada.


    Among the cannabinoids found in cannabis plants, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main active ingredients and are generally considered to be medicinal.


    Among the cannabinoids found in cannabis plants, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main active ingredients and are generally considered to be medicinal.


    Age-related changes in pharmacodynamics and pharmacokinetics, as well as the high prevalence of comorbidities and the use of multiple drugs in the elderly, means that their safety and tolerance to cannabinoids may be different.


    Recently, experts from the Center for Neuropsychiatric Research at King’s University in the United Kingdom conducted a systematic review and meta-analysis of the safety and tolerability of cannabis-based drugs (CBMs) in adults ≥50 years of age.


    Researchers used MEDLINE, PubMed, EMBASE, CINAHL PsychInfo, Cochrane Library and ClinicalTrials.


    A total of 46 RCTs were identified as suitable for inclusion, of which 31 (67%) were conducted in the UK and Europe.


    Compared with the control group, CBMs containing THC significantly increased the incidence of all-cause and treatment-related adverse events (AEs).


    Pure THC increased the incidence of all-cause AEs by 42% and 60% of treatment-related AEs (IRR=1.


    At the same time, the THC:CBD combination significantly increased the risk of 40% AE-related withdrawal, but THC alone had no such effect .


    THC:CBD combination significantly increases the risk of 40% AE-related withdrawal, but THC alone has no such effect.


    CBMs are generally safe and acceptable for the elderly.


    references:

    plos.


    plos.
    org/plosmedicine/article?id=10.
    1371/journal.
    pmed.
    1003524" target="_blank" rel="noopener">Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.